These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10643950)

  • 1. Comments on type 2 diabetes screening and treatment.
    Kolaczynski JW
    Am Fam Physician; 2000 Jan; 61(1):49-50. PubMed ID: 10643950
    [No Abstract]   [Full Text] [Related]  

  • 2. Repaglinide: a short acting insulin secretagogue for postprandial hyperglycaemia.
    Ambavane V; Patil R; Ainapure SS
    J Postgrad Med; 2002; 48(3):246-8. PubMed ID: 12432213
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating type 2 diabetes. When diet and exercise aren't enough, a broad range of medications can help control our blood sugar.
    Blackburn GL
    Health News; 2004 Aug; 10(8):4-5. PubMed ID: 15551454
    [No Abstract]   [Full Text] [Related]  

  • 4. Repaglinide for type 2 diabetes mellitus.
    Med Lett Drugs Ther; 1998 May; 40(1027):55-6. PubMed ID: 9618664
    [No Abstract]   [Full Text] [Related]  

  • 5. For diabetes: a preprandial pill ..
    Health News; 1998 Jul; 4(9):5. PubMed ID: 9693447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antidiabetic drug at every meal. Repaglinide is especially recommended for slender type 2 diabetic patients].
    Landgraf R
    MMW Fortschr Med; 2000 Jul; 142(28-29):29-30. PubMed ID: 10959157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repaglinide dose response? A clinician's viewpoint.
    Strange P; Goldberg RB
    Diabetes Technol Ther; 2000; 2(1):119-21. PubMed ID: 11467310
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes.
    Owens D
    J Assoc Physicians India; 2001 Jan; 49 Spec No():54-61. PubMed ID: 11235607
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of type 2 diabetes. Avoiding postprandial blood glucose peaks!].
    MMW Fortschr Med; 2001 Oct; 143(40):55. PubMed ID: 11692849
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P
    Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination oral and nutritional treatment of late-onset diabetes mellitus (CONTROL DM) trial results.
    Reboussin DM; Goff DC; Lipkin EW; Herrington DM; Summerson J; Steffes M; Crouse RJ; Jovanovic L; Feinglos MN; Probstfield JL; Banerji MA; Pettitt DJ; Williamson J
    Diabet Med; 2004 Oct; 21(10):1082-9. PubMed ID: 15384954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of beta-cell response to different postprandial blood glucose concentrations by prandial repaglinide and combined acarbose/repaglinide application.
    Rosak C; Hofmann U; Paulwitz O
    Diabetes Nutr Metab; 2004 Jun; 17(3):137-42. PubMed ID: 15334790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 diabetes management.
    Nelson G
    Br J Community Nurs; 2002 Jan; 7(1):5. PubMed ID: 11823724
    [No Abstract]   [Full Text] [Related]  

  • 15. [symbol: see text] Nateglinide and [symbol: see text] repaglinide for type 2 diabetes?
    Drug Ther Bull; 2003 Jul; 41(7):52-4. PubMed ID: 12879789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report of experiences. Convenient limitation of blood glucose spikes].
    Henniges W
    MMW Fortschr Med; 2001 Feb; 143(5):57. PubMed ID: 11234526
    [No Abstract]   [Full Text] [Related]  

  • 17. A randomized controlled trial examining combinations of repaglinide, metformin and NPH insulin.
    Davies MJ; Thaware PK; Tringham JR; Howe J; Jarvis J; Johnston V; Kitchener DL; Skinner TC; McNally PG; Lawrence IG
    Diabet Med; 2007 Jul; 24(7):714-9. PubMed ID: 17403126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for type 2 diabetes.
    Treat Guidel Med Lett; 2008 Jul; 6(71):47-54. PubMed ID: 18583949
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral antidiabetic agents: 2004.
    Lebovitz HE
    Med Clin North Am; 2004 Jul; 88(4):847-63, ix-x. PubMed ID: 15308382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premixed biphasic insulin analogs - a choice for pediatric patients with type 2 diabetes rather than type 1 diabetes?
    Danne T
    Pediatr Diabetes; 2006 Feb; 7(1):1-3. PubMed ID: 16489967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.